CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ACRS — Aclaris Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ACRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,830,646
+$851,934 QoQ
Shares Held
346,058
+32.6% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 149 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. ACRS ranks #190 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ACRS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,830,646 | 346,058 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $978,712 | 260,990 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $856,658 | 284,604 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $459,716 | 241,956 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $371,043 | 261,298 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $50,610 | 33,079 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $82,035 | 33,079 | Shares | Sole | 2025-02-06 | |
| 2024-06-30 | $286,776 | 260,706 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $519,974 | 419,334 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $458,146 | 436,330 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,173,152 | 463,234 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,606,986 | 444,261 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,318,679 | 410,220 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,491,094 | 412,133 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,336,199 | 402,554 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,154,293 | 154,319 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,294,092 | 133,068 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,874,395 | 128,913 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,284,488 | 126,916 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,893,635 | 107,838 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $397,882 | 15,789 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $132,667 | 20,505 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $52,697 | 20,505 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $33,218 | 20,505 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $88,090 | 84,702 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||